Skip to content

BELDERM: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

BELDERM

BE 0543.789.522
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€3,911
2024 · -€888+€4,799
Equity
-€99,893
2024 · -€103,804+€3,911
Cash
€5,385
2024 · €610+€4,775
Balance sheet total
€7,299
2024 · €635+€6,664

Largest movements

2024 to 2025
Assets
  • Cash +€4,775

    up €4,775 (+782%), from €610 to €5,385

    mainly Net result for the year (+€3,911) and Trade debts (+€2,738)

  • Receivables within one year +€1,679

    new in 2025: €1,679

    of which Trade receivables: +€1,264

  • Financial fixed assets +€210

    up €210 (+840%), from €25 to €235

Equity and liabilities
  • Profit (loss) carried forward +€3,911

    up €3,911 (+3.4%), from -€116,204 to -€112,293

  • Trade debts +€2,738

    up €2,738 (+1,160%), from €236 to €2,974

Income statement
  • Gross operating margin +€4,767

    up €4,767, from -€775 to €3,992

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€888
Gross operating margin +€4,767
Financial charges +€32
Result 2025 €3,911
raises the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€4,985
Investment -€210
Financing €0
Cash 2024 €610
Net result for the year +€3,911
Receivables within one year -€1,679
Trade debts +€2,738
Tax, wage and social debts +€15
Investment in fixed assets (net) -€210
Cash 2025 €5,385
brings cash intakes cash out
Every line side by side 26 lines
Line Code 2024 2025 Change %
Total assets 20/58 €635 €7,299 +€6,664 +1,049%
Fixed assets 21/28 €25 €235 +€210 +840%
Financial fixed assets 28 €25 €235 +€210 +840%
Current assets 29/58 €610 €7,064 +€6,454 +1,057%
Amounts receivable within one year 40/41 - €1,679 +€1,679
Trade receivables 40 - €1,264 +€1,264
Other amounts receivable 41 - €415 +€415
Cash at bank and in hand 54/58 €610 €5,385 +€4,775 +782%
Total equity and liabilities 10/49 €635 €7,299 +€6,664 +1,049%
Equity 10/15 -€103,804 -€99,893 +€3,911 +3.8%
Contributions 10/11 €12,400 €12,400 = 0.0%
Profit (loss) carried forward 14 -€116,204 -€112,293 +€3,911 +3.4%
Amounts payable 17/49 €104,440 €107,192 +€2,753 +2.6%
Amounts payable within one year 42/48 €104,440 €107,192 +€2,753 +2.6%
Trade debts 44 €236 €2,974 +€2,738 +1,160%
Suppliers 440/4 €236 €2,974 +€2,738 +1,160%
Taxes, remuneration and social security 45 - €15 +€15
Taxes 450/3 - €15 +€15
Other amounts payable 47/48 €104,204 €104,204 = 0.0%
Gross operating margin 9900 -€775 €3,992 +€4,767
Operating profit (loss) 9901 -€775 €3,992 +€4,767
Financial charges 65/66B €113 €81 -€32 -28.2%
Recurring financial charges 65 €113 €81 -€32 -28.2%
Profit (loss) for the period before taxes 9903 -€888 €3,911 +€4,799
Profit (loss) for the period 9904 -€888 €3,911 +€4,799
Profit (loss) for the period to be appropriated 9905 -€888 €3,911 +€4,799

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.